The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection

被引:134
作者
Christian Chaussy
Stefan Thüroff
机构
[1] Department of Urology, Krankenhaus München-Harlaching, Sanatoriumsplatz 2, München
关键词
Catheter Time; HIFU Treatment; High Intensity Focus Ultrasound; Localize Prostate Cancer; Suprapubic Catheter;
D O I
10.1007/s11934-003-0077-0
中图分类号
学科分类号
摘要
To decrease side effects observed after high-intensity focused ultrasound (HIFU) treatment for localized prostate cancer and to re-establish normal micturition in a patient population that often presents with concomitant prostate enlargement, the impact of a combined transurethral resection of the prostate (TURP) and HIFU has been evaluated. TURP and HIFU treatments were performed under the same spinal anesthesia. For the HIFU treatments, the Ablatherm device (EDAP SA, Lyon, France) was used. Selection criteria for HIFU treatment were localized prostate cancer, no previous treatment for prostate cancer, and prostate-specific antigen (PSA) ≤ 15 ng/mL at diagnosis. All patients meeting these criteria were considered for treatment and analysis. PSA nadir and stability, histology, International Prostate Specific Score (IPSS) and IPSS-quality of life, and morbidity were assessed during follow-up; 271 patients were selected: 96 in the HIFU group and 175 in the TURP plus HIFU group. A statistically significant impact was observed on catheter time (40.0 days versus 7.0 in median), incontinence (15.4% versus 6.9%), urinary infection (47.9% versus 11.4%), and the evolution of the post-treatment IPSS (8.91 versus 3.37 in average) in favor of the TURP plus HIFU group. No significant changes were observed regarding efficacy during short-term follow-up when considering a 25% retreatment rate in the HIFU group versus a 4% retreatment rate in the TURP plus HIFU group. The combination of a TURP and HIFU treatment reduces the treatment-related morbidity significantly. The patient management after a combined TURP and HIFU treatment is comparable with the management after a single TURP. © 2003, Current Science Inc.
引用
收藏
页码:248 / 252
页数:4
相关论文
共 11 条
  • [1] Chapelon J.Y., Margonari J., Vernier F., Et al., In vivo effects of high intensity ultrasound on prostatic adenocarcinoma dunning R3327, Cancer Res, 52, pp. 6353-6357, (1992)
  • [2] Chapelon J.Y., Margonari J., Theillere Y., Et al., Effects of highenergy focused ultrasound on kidney tissue in the rat and the dog, Eur Urol, 22, pp. 147-152, (1992)
  • [3] Dosterhof G.O., Cornel E.B., Smits G.A.H.J., Et al., Influence of high intensity focused ultrasound on the development of metastases, Eur Urol, 32, pp. 91-95, (1997)
  • [4] Gelet A., Chapelon J.Y., Margonari J., Et al., Prostatic tissue destruction by high intensity focused ultrasound: experimentation on canine prostate, J Endourol, 7, pp. 249-253, (1993)
  • [5] Gelet A., Chapelon J.Y., Bouvier R., Et al., Treatment of prostate cancer with transrectal focused ultrasound: early clinical experience, Eur Urol, 29, pp. 174-183, (1996)
  • [6] Gelet A., Chapelon J.Y., Bouvier R., Et al., Local control of prostate cancer by transrectal high intensity focused ultrasound therapy: preliminary results, J Urol, 161, pp. 156-162, (1999)
  • [7] Chaussy C., Thuroff S., Results and side effects of high intensity focused ultrasound in localized prostate cancer, J Endourol, 15, pp. 437-440, (2001)
  • [8] Thuroff S., Chaussy C., High intensity focused ultrasound: complications and adverse events, Mol Urol, 4, pp. 183-187, (2000)
  • [9] Gelet A., Chapelon J.Y., Bouvier R., Et al., Transrectal high intensity focused ultrasound for the treatment of localized prostate cancer: factors influencing the outcome, Eur Urol, 40, pp. 124-129, (2001)
  • [10] Chaussy C., Thuroff S., High intensity focused ultrasound in prostate cancer: results after 3 years, Mol Urol, 4, pp. 179-182, (2000)